Main > NEUROLOGY. > Multiple Sclerosis > Treatment > Paclitaxel. > Patent. > Claims > Claim 1: Multiple Sclerosis Treat. > Method. Adm. to Patient Paclitaxel. > Claim 2: Systemic Adm. Claim 3: > Oral or IntraVenous Adm. Claim 4: > Dosage: 10-75 mg/m.sup.2 Once > Every 1-4 Weeks. Claim 5: Polymer. > Claim 6: Compn Form: MicroSpheres > Claim 7: Lactic Acid/Glycolic Acid > CoPol. Claim 8: Poly(Caprolactone). > Claim 9: Poly(Lactic Acid). Claim > 10: Caprolactone/Lactic Acid CoPol. > Claim 11: PolyEthylene Glycol. > Claim 12: Ethylene/Vinyl Acetate > CoPol. Claim 13: Paclitaxel Compn > & Iso-Pr Myristate. Claim 14: > Paclitaxel Compn & Glycol. Claim 15 > : Glycol: EthoxyDiGlycol. Claims 19 > ,20,21: Paclitaxel Dose=25,50 & 75 > mg/m.sup.2 resp. Claim 21: > Paclitaxel Infused for=1-2 hours. > Claim 22: PreMedication: > HydroCortisone. Claim 23: PreMed.: > Di-Ph-Hydramine & Cimetidine or > Ranitidine. Patent Assignee > Abstract: Psoriasis.
Abstract: Psoriasis.'s products
This section has no products